BRODIE STEVEN G. 4
4 · NEOGENOMICS INC · Filed Oct 24, 2018
Insider Transaction Report
Form 4
BRODIE STEVEN G.
Chief Scientific Officer
Transactions
- Exercise/Conversion
Common Stock
2018-10-22$3.45/sh+13,334$46,002→ 45,953 total - Exercise/Conversion
Stock Option (Right to Buy)
2018-10-22−13,334→ 0 totalExercise: $3.45From: 2015-03-05Exp: 2019-03-05→ Common Stock (13,334 underlying)
Holdings
- 120,000
Stock Option (Right to Buy)
Exercise: $4.78From: 2016-05-04Exp: 2020-05-04→ Common Stock (120,000 underlying) - 50,000
Stock Option (Right to Buy)
Exercise: $7.52From: 2018-04-28Exp: 2022-04-28→ Common Stock (50,000 underlying) - 100,000
Stock Option (Right to Buy)
Exercise: $7.15From: 2017-04-20Exp: 2021-04-20→ Common Stock (100,000 underlying) - 58,000
Stock Option (Right to Buy)
Exercise: $8.03From: 2019-02-26Exp: 2023-02-26→ Common Stock (58,000 underlying)
Footnotes (4)
- [F1]On April 28, 2017, Dr. Brodie was granted 50,000 stock options. These options vest ratably over the next three anniversary dates of the grant date.
- [F2]On April 20, 2016, Dr. Brodie was granted 100,000 stock options. These options vest ratably over the first three anniversary dates of the grant date.
- [F3]On May 4, 2015 Dr, Brodie was granted 120,000 stock options. These options vest ratably over the next three anniversary dates of the grant date.
- [F4]On February 26, 2018, Dr. Brodie was granted 58,000 stock options. These options vest ratably over the next three anniversary dates of the grant date.